• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Research letter: BRAF-inhibitor induced panniculitis - A systematic review.

作者信息

Kye Yae, Zhao Grant, Guhan Samantha, Nunes Denise, Nguyen Cuong V

机构信息

Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Paul L Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas.

Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

出版信息

J Am Acad Dermatol. 2024 Feb;90(2):420-423. doi: 10.1016/j.jaad.2023.10.008. Epub 2023 Nov 7.

DOI:10.1016/j.jaad.2023.10.008
PMID:37943239
Abstract
摘要

相似文献

1
Research letter: BRAF-inhibitor induced panniculitis - A systematic review.研究信函：BRAF抑制剂诱发的脂膜炎——一项系统评价
J Am Acad Dermatol. 2024 Feb;90(2):420-423. doi: 10.1016/j.jaad.2023.10.008. Epub 2023 Nov 7.
2
What impact will BRAF/MEK-inhibitors have on the melanoma treatment armamentarium and are there challenges ahead?BRAF/MEK抑制剂对黑色素瘤治疗手段会产生何种影响，未来是否存在挑战？
Expert Opin Pharmacother. 2023 May-Aug;24(10):1101-1103. doi: 10.1080/14656566.2023.2211765. Epub 2023 May 8.
3
Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
J Am Acad Dermatol. 2022 Aug;87(2):e85-e88. doi: 10.1016/j.jaad.2022.04.053. Epub 2022 May 5.
4
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor.两例BRAF突变转移性黑色素瘤患者接受BRAF抑制剂和MEK抑制剂联合治疗时脂膜炎的临床观察
Eur J Dermatol. 2015 Apr;25(2):177-80. doi: 10.1684/ejd.2014.2512.
5
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.达拉非尼联合曲美替尼与维莫非尼单药治疗不可切除或转移性皮肤 BRAF Val600 突变阳性黑色素瘤患者的健康相关生活质量比较（COMBI-v）：一项开放标签、随机、3 期临床试验结果。
Lancet Oncol. 2015 Oct;16(13):1389-98. doi: 10.1016/S1470-2045(15)00087-X.
6
[Efficacy of the encorafenib + binimetinib combination in a BRAF mutated metastatic melanoma case report].恩考芬尼+比美替尼联合用药治疗BRAF突变转移性黑色素瘤的疗效：病例报告
Recenti Prog Med. 2022 Jun;113(6):28e-30e. doi: 10.1701/3827.38162.
7
[Treatment combinations in BRAF-mutant metastatic melanoma.].[BRAF 突变转移性黑色素瘤的治疗组合。]
Recenti Prog Med. 2021 Apr;112(4):40e-43e. doi: 10.1701/3584.35696.
8
Successful rechallenge therapy for BRAF/MEK inhibitor-resistant multiple brain metastases of melanoma.成功重新挑战治疗黑色素瘤 BRAF/MEK 抑制剂耐药性多发脑转移。
J Dermatol. 2021 Aug;48(8):1291-1295. doi: 10.1111/1346-8138.15969. Epub 2021 May 21.
9
Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma.BRAF 突变型黑色素瘤脑转移患者中 BRAF 抑制和 MEK 抑制的临床及影像学反应
Melanoma Res. 2018 Apr;28(2):126-133. doi: 10.1097/CMR.0000000000000429.
10
Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report.黑色素瘤患者从达拉非尼/曲美替尼联合治疗转换为恩考芬尼/比美替尼联合治疗并伴有血清乳酸脱氢酶水平变化：一例报告
Dermatol Ther. 2022 Apr;35(4):e15301. doi: 10.1111/dth.15301. Epub 2022 Jan 11.